BrainStorm Cell Therapeutics
BCLI
#10415
Rank
โ‚ฌ5.28 M
Marketcap
0,48ย โ‚ฌ
Share price
-6.67%
Change (1 day)
-68.62%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2025 (TTM): -1,72ย โ‚ฌ

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -1,62ย โ‚ฌ. In 2015 the company made an earnings per share (EPS) of -5,77ย โ‚ฌ an increase over its 2014 EPS that were of -8,72ย โ‚ฌ.

EPS history for BrainStorm Cell Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-1,72ย โ‚ฌ
2015-5,77ย โ‚ฌ-33.82%
2014-8,72ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
5,57ย โ‚ฌ-443.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-5,38ย โ‚ฌ 231.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,43ย โ‚ฌ 111.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
9,39ย โ‚ฌ-678.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-2,66ย โ‚ฌ 63.68%๐Ÿ‡บ๐Ÿ‡ธ USA